EXECUTIVE ENGAGEMENTS
OUTREACH
10662
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1279
Interactions with Platform & by Email
PARTICIPANTS
322
Unique # Participated
VALIDATIONS
146
Responses Validated*
COMPETITORS
46
Responses Validated*
BRANDS
239
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
63
PAGES
139
EDITION
18
PRICE
USD $5800
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for DNA Probes-Based Diagnostics estimated at US$14.8 Billion in the year 2020, is projected to reach a revised size of US$20.5 Billion by 2027, growing at a CAGR of 4.8% over the analysis period 2020-2027. Infectious Diseases, one of the segments analyzed in the report, is projected to record a 4.7% CAGR and reach US$12.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cancer segment is readjusted to a revised 5.1% CAGR for the next 7-year period.
The DNA Probes-Based Diagnostics market in the U.S. is estimated at US$4.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 3.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.
In the global Genetic Predisposition segment, USA, Canada, Japan, China and Europe will drive the 6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$1.7 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$2.4 Billion by the year 2027.
SELECT PLAYERS
Abbott Molecular; Beckman Coulter Inc.; Becton, Dickinson and Company; bioMérieux; F. Hoffmann-La Roche Ltd.; GE Healthcare Life Sciences; Luminex Corporation; QIAGEN N.V.; Siemens Healthineers; Thermo Fischer Scientific Inc.
SEGMENTS
» Application (Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics, Other Applications)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| What are DNA-Probes? |
| Recent Market Activity |
| DNA-based Diagnostics - A Prelude |
| DNA Tests: Finding Use in Numerous Applications |
| DNA Probes: Robust Growth Ahead |
| Developed Markets: Traditional Revenue Contributors |
| The United States: Unraveling the Country’s Edge in DNA-based Diagnostics |
| Infectious Diseases Tests Dominate the DNA-based Diagnostics Market |
| Developing Countries Excel in Growth Prospects |
| Decoding the Genetic Puzzle |
| Growth Drivers in a Nutshell |
| Growth Inhibitors in a Nutshell |
| Genetic Profiling of Pathogens: A Road Less Traveled |
| Roche's Entry into the Hall of Molecular Fame |
| DNA Technology: An Evolutionary Scan |
| Tracking Landmark Breakthroughs in DNA Diagnostics: 1953-2005 |
| Market Opportunities |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Abbott Molecular (USA) |
| Beckman Coulter, Inc. (USA) |
| Becton, Dickinson and Company (USA) |
| bioMérieux (France) |
| F. Hoffmann-La Roche Ltd. (Switzerland) |
| GE Healthcare Life Sciences (UK) |
| Luminex Corporation (USA) |
| QIAGEN N.V. (Netherlands) |
| Siemens Healthineers (Germany) |
| Thermo Fisher Scientific, Inc. (USA) |
| 3. MARKET TRENDS & DRIVERS |
| World's Aging Population Drives the Popularity of DNA-Probe Tests |
| Global Aging Population Statistics - Opportunity Indicators |
| Rising Incidence of Chronic Diseases Fuels Demand for DNA Probes Based Diagnostics |
| AIDS: A Global Epidemic |
| Rise in Healthcare Spending in Developing Nations Bode Well for Market Growth |
| Reimbursements: "Under the Umbrella" |
| Evolution of New & Virulent Infectious Agents |
| Challenges in Widespread Deployment of DNA-based Diagnostics |
| DNA Probe Technology Gains Prominence in Diagnosing Vaginitis |
| Gene Banks - A Ray of Hope for the Future |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for DNA Probes-Based Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for DNA Probes-Based Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for DNA Probes-Based Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Genetic Predisposition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Genetic Predisposition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Genetic Predisposition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Identity/Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Identity/Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Identity/Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for DNA Probes-Based Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for DNA Probes-Based Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for DNA Probes-Based Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for DNA Probes-Based Diagnostics by Application - Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for DNA Probes-Based Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer, Genetic Predisposition, Identity/Forensics and Other Applications for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 46 |
With the Global Economy Walking the Tightrope, It's the Numbers that Help Understand this Uncertain World.
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com